The slip
PARKINSON RECEIPTno. 4807
21 Oct 2026, 02:12 UTCdopamine neurons, braak
predictionNRCAM in dopamine neurons tracks Braak Lewy-body stage
registered58c34b0a18d7cd39
discovery+0.18 p=0.652 n=9
replication+0.20 p=0.607 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho +0.18, p 0.652)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT56d5f9c7fe78678c85c34f7c…
follows 0bb8e433f27a…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 4807: NRCAM in dopamine neurons, braak
- power
- full sample +0.09 (p 0.735, n 18), 95% CI -0.40 to +0.53. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.14 (p 0.579, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.09 (p 0.715, n 18). could be the mix.
- skeptic
- leave-one-out range -0.03 to +0.23, sign flips 1; without severely affected donors +0.09 (p 0.735, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for NRCAM in dopamine neurons.
case closed: nothing better to follow up.